Fusion Antibodies (FAB)

Sector:

Health Care

Index:

FTSE AIM All-Share

 3.80p
   
  • Change Today:
      0.000p
  • 52 Week High: 44.00
  • 52 Week Low: 3.20
  • Currency: UK Pounds
  • Shares Issued: 95.37m
  • Volume: 0
  • Market Cap: £3.62m
  • RiskGrade: 464

Regulatory News

Change of auditor 16-Apr-2024 07:00 RNS
Contract to develop a bespoke OptiPhage library 15-Apr-2024 07:00 RNS
Block admission six monthly return 02-Apr-2024 14:34 RNS
Total Voting Rights 28-Mar-2024 17:00 RNS
Holding(s) in Company 11-Mar-2024 15:04 RNS
Holding(s) in Company 11-Mar-2024 09:10 RNS
Holding(s) in Company 08-Mar-2024 15:09 RNS
Result of General Meeting and Total Voting Rights 05-Mar-2024 10:40 RNS
Total Voting Rights 29-Feb-2024 17:00 RNS
First purchase order under MSA 27-Feb-2024 07:00 RNS
Grant of options and issue of shares to directors 14-Feb-2024 07:15 RNS
Placing to raise £1,375,000 14-Feb-2024 07:00 RNS
Follow-on project award and R&D update 06-Feb-2024 07:00 RNS
HMRC R&D tax credit 01-Feb-2024 07:00 RNS
Director/PDMR Shareholding 04-Dec-2023 12:26 RNS
 

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

FAB Market Data

Currency UK Pounds
Share Price 3.80p
Change Today 0.000p
% Change 0.00 %
52 Week High 44.00
52 Week Low 3.20
Volume 0
Shares Issued 95.37m
Market Cap £3.62m
RiskGrade 464

FAB Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
44.91% below the market average44.91% below the market average44.91% below the market average44.91% below the market average44.91% below the market average
9.68% below the sector average9.68% below the sector average9.68% below the sector average9.68% below the sector average9.68% below the sector average
Price Trend
94.15% below the market average94.15% below the market average94.15% below the market average94.15% below the market average94.15% below the market average
89.19% below the sector average89.19% below the sector average89.19% below the sector average89.19% below the sector average89.19% below the sector average
Income Not Available
Growth
20.94% above the market average20.94% above the market average20.94% above the market average20.94% above the market average20.94% above the market average
38.89% above the sector average38.89% above the sector average38.89% above the sector average38.89% above the sector average38.89% above the sector average

FAB Dividends

No dividends found

Trades for --2024

Time Volume / Share Price
0 @ 0.000p

FAB Key Personnel

Chair Simon Gordon Douglas
CEO Adrian Kinkaid

Top of Page